Test cannabis-based treatment for nerve pain
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This Phase 2 study tests cannabis-derived products to see if they reduce neuropathic (nerve-related) pain in veterans. It may help people whose pain is persistent and causes significant daily impact, especially if certain exam tests show allodynia (pain from normally non-painful touch).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and sign a consent form for the study
- You are a veteran age 21 or older
- Your pain is confirmed to be neuropathic (nerve-related) and persistent/high-impact
- You have allodynia, confirmed by a specific brush test during screening
- If you could become pregnant, you agree to use birth control during the study
- You must be willing to avoid cannabis and cannabis-based products during the whole study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.
This early study looks at how the brain may respond to cannabis to reduce long-lasting lower back pain. You may be asked to follow strict rules about cannabis, opioids, and safety checks (including MRI) to help researchers understand the brain mechanisms.
This study tests a high-CBD cannabis extract (BRC-002) to see if it can help reduce pain and improve health in people with Complex Regional Pain Syndrome (CRPS). Participants will not use opioids or other cannabis during the study.
This trial studies whether a cannabis extract can reduce acute nerve-related pain in the back and lessen how much pain medication you need. It may help people with a short-term episode of “shooting” nerve pain from the spine.
This Phase 2 study tests how a new cannabinoid product affects people with ongoing musculoskeletal pain (like arthritis or injuries). It’s meant to see whether the product can improve pain for eligible adults who are not already using CBD regularly.
This trial studies whether taking cannabis by mouth can safely reduce chronic spine pain and improve daily comfort. You may be eligible if you have long-lasting spine pain and can follow study rules about stopping or limiting other cannabis and certain other treatments.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.